SEC 13F Intelligence

Ghost Tree Capital, LLC / TREUR

Ghost Tree Capital, LLC’s Trillium Therapeutics Inc Position

Does Ghost Tree Capital, LLC own Trillium Therapeutics Inc (TREUR)? Not currently — the last reported position was 1.25M shares worth $12M in Q2 2021; the fund’s latest 13F (Q3 2024) no longer reports it.

Position Value
$12M
Q2 2021
Shares
1.25M
% of Portfolio
+3.33%
Quarters Held
6
position exited

Position History TREUR

Reported value by quarter
Q1 ’20: $3MQ1 ’20Q2 ’20: $12MQ2 ’20Q3 ’20: $28MQ3 ’20Q4 ’20: $29MQ4 ’20Q1 ’21: $21MQ1 ’21Q2 ’21: $12MQ2 ’21filingsflow.com
QuarterSharesValue% of Portfolio
Q2 20211.25M$12M+3.33%
Q1 20211.95M$21M+4.92%
Q4 20201.95M$29M+6.39%
Q3 20201.95M$28M+8.01%
Q2 20201.52M$12M+3.25%
Q1 2020825.0K$3M+0.88%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Ghost Tree Capital, LLC’s full portfolio or all institutional holders of TREUR.